Format

Send to

Choose Destination
Br J Haematol. 2018 Oct;183(1):127-129. doi: 10.1111/bjh.14900. Epub 2017 Aug 18.

Is there a role for minimal residual disease monitoring in the management of patients with hairy-cell leukaemia?

Author information

1
Department of Haematology, Hospital Clínic, IDIBAPS, Barcelona, Spain.
2
Hematopathology Unit, Hospital Clínic, IDIBAPS, Barcelona, Spain.
3
CIBERONC, ISCIII, MINECO, Spain.

KEYWORDS:

hairy-cell leukaemia; immunophenotyping; minimal residual disease; purine analogues

PMID:
28832940
DOI:
10.1111/bjh.14900

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center